"It's really a bit of science fiction"
We’re proud to share an insightful new interview with our CEO, Hugo de Wit, featured by SoftBank Vision Fund. In this Q&A, Hugo discusses how LUMICKS is enabling scientists to visualize the molecular machinery of life in real time and how that’s accelerating the development of next-generation therapies.
“It’s really a bit of science fiction,” Hugo says. “Some people compare it to building a rocket ship.”
At LUMICKS, we’re building the technology that allows researchers to uncover the molecular mechanisms behind cancer and other diseases, enabling smarter drug design and better therapeutic outcomes.
We’re honored to be supported by visionary partners like SoftBank Vision Fund as we continue scaling our mission to advance molecular and cellular medicine.
Read the full interview: https://visionfund.com/insights/lumicks-hugo-de-witt-qa
.jpg)
